A Randomized, Triple-Blind, Placebo-Controlled, Crossover Study to Investigate the Efficacy of a Single Dose of AlphaWave ® l-Theanine on Stress in a Healthy Adult Population

ConclusionThis study was conducted during the SARS-CoV-2 pandemic, which has had a rapid and significant effect on both physical and mental health around the world. A single dose of AlphaWave®l-Theanine significantly increased frontal region alpha power compared to placebo in response to an acute stress challenge. These changes are indicative of relaxation in the brain and suggest a calming response. AlphaWave®l-Theanine was found to be safe and well tolerated by participants.Trial RegistrationClinicalTrials.gov identifier NCT04706494.
Source: Neurology and Therapy - Category: Neurology Source Type: research